Mocon is a Minneapolis, US supplier of detectors, instruments, systems and package testing instrumentation for the medical, pharmaceutical, and other industries worldwide.
Mocon will initially dedicate some of its r&d resources to a development project to help bring a high-throughput pathogen (Listeria, Salmonella, E. coli, etc.) screening process to the meat, poultry, seafood, produce and dairy industries. The firm also has the opportunity to build on its food and packaging expertise and expand into the growing food safety testing market.
Luxcel, set up in 2002 with support from Enterprise Ireland as a spin out from University College Cork, will now have access to significant sales, marketing, manufacturing and r&d resources to target major global markets through Mocon’s international sales and service channels. “This investment will enable our company to provide even greater value to the global food and pharmaceutical sectors by providing a new generation of products and services including faster, less expensive testing for pathogens,” said Robert Demorest, chief executive of Mocon.
Enterprise Ireland has also added to its equity interest in Luxcel.
Richard Fernandes, ceo of Luxcel, added: “As part of this new alliance, Mocon intends to design and manufacture dedicated instrumentation to measure Luxcel sensors, and market these instruments and a wider range of Luxcel sensor products in the US and other markets. This is a very exciting development for Luxcel, and the fact that Mocon has also come on board as an investor is a tremendous accolade for us.”
Contact www.mocon.com www.luxcel.com